Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice

Bibliographic Details
Main Authors:	Wang, Qingshan, Shin, Eun-Joo, Nguyen, Xuan-Khanh Thi, Li, Quan, Bach, Jae-Hyung, Bing, Guoying, Kim, Won-Ki, Kim, Hyoung-Chun, Hong, Jau-Shyong
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409049/

Similar Items

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
by: Jung, Un Ju, et al.
Published: (2014)

Nigrostriatal dopaminergic depletion increases static orofacial allodynia
by: Dieb, Wisam, et al.
Published: (2016)

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration
by: Singh, Anand Kumar, et al.
Published: (2012)

Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
by: Jeon, B. S.
Published: (1997)

Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
by: Dieb, Wisam, et al.
Published: (2014)

Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System
by: Song, Xiao-Yao, et al.
Published: (2015)

Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
by: Lee, Tony Tung-Yin, et al.
Published: (2012)

Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain
by: Jung, Un Ju, et al.
Published: (2014)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
by: Chung, Young Cheul, et al.
Published: (2013)

Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
by: Lugo-Huitrón, Rafael, et al.
Published: (2013)

Discovery of Amphipathic Dynorphin A Analogues to Inhibit the Neuroexcitatory Effects of Dynorphin A through Bradykinin Receptors in the Spinal Cord
by: Lee, Yeon Sun, et al.
Published: (2014)

Allopregnanolone and neurogenesis in the nigrostriatal tract
by: Wang, Jun Ming
Published: (2014)

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
by: Liu, Jie, et al.
Published: (2015)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
by: Blesa, Javier, et al.
Published: (2011)

Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function
by: Ciron, C., et al.
Published: (2012)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
by: Machado, A., et al.
Published: (2011)

Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit
by: Pham, Anh H., et al.
Published: (2012)

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
by: Pellegrini, Carolina, et al.
Published: (2016)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
by: Sastry, Namratha, et al.
Published: (2015)

GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
by: Kumar, Anmol, et al.
Published: (2015)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
by: Aguirre, Pabla, et al.
Published: (2015)

Correction: GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function
by: Kumar, Anmol, et al.
Published: (2016)

Correction: 1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque
by: Lei, Xiaoguang, et al.
Published: (2016)

Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
by: Harrison, Ian F., et al.
Published: (2016)

1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque
by: Lei, Xiaoguang, et al.
Published: (2015)

Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice
by: Chien, Chia-Hung, et al.
Published: (2016)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
by: d’Anglemont de Tassigny, Xavier, et al.
Published: (2015)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
by: Cai, Huaibin, et al.
Published: (2014)

Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice
by: Beck, Goichi, et al.
Published: (2016)

A Genetic Polymorphism of the Endogenous Opioid Dynorphin Modulates Monetary Reward Anticipation in the Corticostriatal Loop
by: Votinov, Mikhail, et al.
Published: (2014)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
by: Jiang, Lulu, et al.
Published: (2016)

Exposure to Extremely Low Frequency Magnetic Fields Induces Fos-Related Antigen-Immunoreactivity Via Activation of Dopaminergic D1 Receptor
by: Shin, Eun-Joo, et al.
Published: (2011)

Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
by: Wang, Shijun, et al.
Published: (2016)

A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
by: Carlsson, Arvid, et al.
Published: (2006)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
by: Buddhala, Chandana, et al.
Published: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
by: Kaasinen, Valtteri
Published: (2015)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
by: Tan, Wen-Qi, et al.
Published: (2015)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
by: Machado, A., et al.
Published: (2011)

Dynorphin Activates Quorum Sensing Quinolone Signaling in Pseudomonas aeruginosa
by: Zaborina, Olga, et al.
Published: (2007)

Correction: Dynorphin Activates Quorum Sensing Quinolone Signaling in Pseudomonas aeruginosa
by: Zaborina, Olga, et al.
Published: (2007)